United Kingdom Uterine Cancer Market Size & Outlook, 2025-2033


United Kingdom Uterine Cancer Market Insights

  • Based on Reed Intelligence findings, the United Kingdom Uterine Cancer Market reached USD 430.94 Million in 2024 and is estimated to attain USD 682.03 Million by 2033.
  • From 2026 to 2033, the United Kingdom market is expected to grow at a steady CAGR of 5.3%.
  • Within the By Type category, Endometrial Adenocarcinoma dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Uterine Sarcoma is forecasted to deliver the fastest growth, positioning it as the most lucrative By Type segment.

Other Key Findings


  • In 2024, United Kingdom accounted for 6.88% of the global Uterine Cancer Market size.
  • By 2033, United States is expected to lead the global Uterine Cancer Market in terms of market size.
  • Within Europe, Germany is projected to dominate the regional Uterine Cancer Market size by 2033.
  • Germany is identified as the fastest-growing market in Europe, anticipated to reach USD 861.8 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 430.94 Million
Market Size In 2033 USD 682.03 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 5.3% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends